Year |
Citation |
Score |
2023 |
Zhu K, Suskiewicz MJ, Chatrin C, Strømland Ø, Dorsey BW, Aucagne V, Ahel D, Ahel I. DELTEX E3 ligases ubiquitylate ADP-ribosyl modification on nucleic acids. Nucleic Acids Research. PMID 38000390 DOI: 10.1093/nar/gkad1119 |
0.697 |
|
2023 |
Đukić N, Strømland Ø, Elsborg JD, Munnur D, Zhu K, Schuller M, Chatrin C, Kar P, Duma L, Suyari O, Rack JGM, Baretić D, Crudgington DRK, Groslambert J, Fowler G, ... ... Ahel D, et al. PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities. Science Advances. 9: eadi2687. PMID 37703374 DOI: 10.1126/sciadv.adi2687 |
0.75 |
|
2023 |
Groslambert J, Prokhorova E, Wondisford AR, Tromans-Coia C, Giansanti C, Jansen J, Timinszky G, Dobbelstein M, Ahel D, O'Sullivan RJ, Ahel I. The interplay of TARG1 and PARG protects against genomic instability. Cell Reports. 42: 113113. PMID 37676774 DOI: 10.1016/j.celrep.2023.113113 |
0.73 |
|
2023 |
Suskiewicz MJ, Munnur D, Strømland Ø, Yang JC, Easton LE, Chatrin C, Zhu K, Baretić D, Goffinont S, Schuller M, Wu WF, Elkins JM, Ahel D, Sanyal S, Neuhaus D, et al. Updated protein domain annotation of the PARP protein family sheds new light on biological function. Nucleic Acids Research. PMID 37326024 DOI: 10.1093/nar/gkad514 |
0.714 |
|
2023 |
Carnie CJ, Armstrong L, Sebesta M, Ariza A, Wang X, Graham E, Zhu K, Ahel D. ERCC6L2 mitigates replication stress and promotes centromere stability. Cell Reports. 42: 112329. PMID 37014751 DOI: 10.1016/j.celrep.2023.112329 |
0.386 |
|
2022 |
Zhu K, Suskiewicz MJ, Hloušek-Kasun A, Meudal H, Mikoč A, Aucagne V, Ahel D, Ahel I. DELTEX E3 ligases ubiquitylate ADP-ribosyl modification on protein substrates. Science Advances. 8: eadd4253. PMID 36197986 DOI: 10.1126/sciadv.add4253 |
0.705 |
|
2021 |
Hendriks IA, Buch-Larsen SC, Prokhorova E, Elsborg JD, Rebak AKLFS, Zhu K, Ahel D, Lukas C, Ahel I, Nielsen ML. The regulatory landscape of the human HPF1- and ARH3-dependent ADP-ribosylome. Nature Communications. 12: 5893. PMID 34625544 DOI: 10.1038/s41467-021-26172-4 |
0.74 |
|
2021 |
Rack JGM, Liu Q, Zorzini V, Voorneveld J, Ariza A, Honarmand Ebrahimi K, Reber JM, Krassnig SC, Ahel D, van der Marel GA, Mangerich A, McCullagh JSO, Filippov DV, Ahel I. Mechanistic insights into the three steps of poly(ADP-ribosylation) reversal. Nature Communications. 12: 4581. PMID 34321462 DOI: 10.1038/s41467-021-24723-3 |
0.73 |
|
2021 |
Prokhorova E, Zobel F, Smith R, Zentout S, Gibbs-Seymour I, Schützenhofer K, Peters A, Groslambert J, Zorzini V, Agnew T, Brognard J, Nielsen ML, Ahel D, Huet S, Suskiewicz MJ, et al. Serine-linked PARP1 auto-modification controls PARP inhibitor response. Nature Communications. 12: 4055. PMID 34210965 DOI: 10.1038/s41467-021-24361-9 |
0.757 |
|
2021 |
Prokhorova E, Agnew T, Wondisford AR, Tellier M, Kaminski N, Beijer D, Holder J, Groslambert J, Suskiewicz MJ, Zhu K, Reber JM, Krassnig SC, Palazzo L, Murphy S, Nielsen ML, ... ... Ahel D, et al. Unrestrained poly-ADP-ribosylation provides insights into chromatin regulation and human disease. Molecular Cell. PMID 34019811 DOI: 10.1016/j.molcel.2021.04.028 |
0.739 |
|
2020 |
Hewitt G, Borel V, Segura-Bayona S, Takaki T, Ruis P, Bellelli R, Lehmann LC, Sommerova L, Vancevska A, Tomas-Loba A, Zhu K, Cooper C, Fugger K, Patel H, Goldstone R, ... ... Ahel D, et al. Defective ALC1 nucleosome remodeling confers PARPi sensitization and synthetic lethality with HRD. Molecular Cell. PMID 33333017 DOI: 10.1016/j.molcel.2020.12.006 |
0.764 |
|
2020 |
Rack JGM, Zorzini V, Zhu Z, Schuller M, Ahel D, Ahel I. Viral macrodomains: a structural and evolutionary assessment of the pharmacological potential. Open Biology. 10: 200237. PMID 33202171 DOI: 10.1098/rsob.200237 |
0.684 |
|
2020 |
Suskiewicz MJ, Zobel F, Ogden TEH, Fontana P, Ariza A, Yang JC, Zhu K, Bracken L, Hawthorne WJ, Ahel D, Neuhaus D, Ahel I. HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation. Nature. PMID 32028527 DOI: 10.1038/S41586-020-2013-6 |
0.774 |
|
2017 |
Sebesta M, Cooper CDO, Ariza A, Carnie CJ, Ahel D. Structural insights into the function of ZRANB3 in replication stress response. Nature Communications. 8: 15847. PMID 28621305 DOI: 10.1038/ncomms15847 |
0.33 |
|
2013 |
Sharifi R, Morra R, Appel CD, Tallis M, Chioza B, Jankevicius G, Simpson MA, Matic I, Ozkan E, Golia B, Schellenberg MJ, Weston R, Williams JG, Rossi MN, Galehdari H, ... ... Ahel D, et al. Deficiency of terminal ADP-ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease. The Embo Journal. 32: 1225-37. PMID 23481255 DOI: 10.1038/Emboj.2013.51 |
0.735 |
|
2012 |
Weston R, Peeters H, Ahel D. ZRANB3 is a structure-specific ATP-dependent endonuclease involved in replication stress response. Genes & Development. 26: 1558-72. PMID 22759634 DOI: 10.1101/gad.193516.112 |
0.39 |
|
2011 |
Mehrotra PV, Ahel D, Ryan DP, Weston R, Wiechens N, Kraehenbuehl R, Owen-Hughes T, Ahel I. DNA repair factor APLF is a histone chaperone. Molecular Cell. 41: 46-55. PMID 21211722 DOI: 10.1016/J.Molcel.2010.12.008 |
0.764 |
|
2009 |
Ahel D, Horejsí Z, Wiechens N, Polo SE, Garcia-Wilson E, Ahel I, Flynn H, Skehel M, West SC, Jackson SP, Owen-Hughes T, Boulton SJ. Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1. Science (New York, N.Y.). 325: 1240-3. PMID 19661379 DOI: 10.1126/Science.1177321 |
0.789 |
|
2008 |
Ahel I, Ahel D, Matsusaka T, Clark AJ, Pines J, Boulton SJ, West SC. Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins. Nature. 451: 81-5. PMID 18172500 DOI: 10.1038/Nature06420 |
0.786 |
|
2006 |
Bilokapic S, Maier T, Ahel D, Gruic-Sovulj I, Söll D, Weygand-Durasevic I, Ban N. Structure of the unusual seryl-tRNA synthetase reveals a distinct zinc-dependent mode of substrate recognition Embo Journal. 25: 2498-2509. PMID 16675947 DOI: 10.1038/Sj.Emboj.7601129 |
0.723 |
|
2005 |
Ahel D, Slade D, Mocibob M, Söll D, Weygand-Durasevic I. Selective inhibition of divergent seryl-tRNA synthetases by serine analogues Febs Letters. 579: 4344-4348. PMID 16054140 DOI: 10.1016/J.Febslet.2005.06.073 |
0.725 |
|
Show low-probability matches. |